Raphael J Mannino's Net Worth

$11.6 Million

Estimate Recalculated Apr 10, 2025 08:46PM EST

Who is Raphael J Mannino

Raphael J Mannino has an estimated net worth of $11.6 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, BIOVEST INTERNATIONAL INC, and Matinas BioPharma Holdings, Inc..

SEC CIK

Raphael J Mannino's CIK is 0001196697

Past Insider Trading and Trends

2021 was Raphael J Mannino's most active year for acquiring shares with 5 total transactions. Raphael J Mannino's most active month to acquire stocks was the month of May. 2013 was Raphael J Mannino's most active year for disposing of shares, totalling 6 transactions. Raphael J Mannino's most active month to dispose stocks was the month of June. 2008 saw Raphael J Mannino paying a total of $97,800.00 for 154,765 shares, this is the most they've acquired in one year. In 2004 Raphael J Mannino cashed out on 27,600 shares for a total of $109,572.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIODELIVERY SCIENCES INTERNATIONAL INC

Executive VP & CSO
Updated Aug 08, 2008
Form 4
19.77K
Aug 08, 2008
19.77K
Grant
Jul 24
Form 4
$1.63
$97.80K
Feb 01, 2008
360.28K
Options
Jan 31
Form 4
20.00K
Sep 07, 2007
375.70K
Grant
Sep 05
Form 4
19.59%
8.54K
Aug 01, 2007
355.70K
Grant
Jul 27 - Jul 28
Form 4
$1.70
$34.00K
Jun 25, 2007
347.17K
Options
Jun 25
Form 4
-3.77%
-5.20K
$4.82
-$25.05K
Jun 14, 2007
347.17K
Sale
Jun 12
Form 4
-9.70%
-14.80K
$5.03
-$74.47K
Jun 08, 2007
352.37K
Sale
Jun 06
Form 4
40.00K
Sep 07, 2005
427.51K
Grant
Jul 29 - Jul 28
Form 4
-15.11%
-27.60K
$3.97
-$109.57K
Apr 16, 2004
393.11K
Sale
Apr 12
Showing 9 results

BIOVEST INTERNATIONAL INC

Investor
Updated Aug 23, 2013
Form 4
-100.00%
-689.25K
Aug 23, 2013
Disposition
Jul 09
Form 4
176.75K
Apr 03, 2012
176.75K
Grant
Mar 30
Form 4
302.50K
Aug 20, 2010
302.50K
Grant
Feb 24 - Feb 22
Form 4
75.00K
Apr 15, 2008
75.00K
Grant
Apr 11
Form 4
125.00%
75.00K
Oct 24, 2006
135.00K
Grant
Oct 19
Form 3
Jun 24, 2003
Showing 6 results

Matinas BioPharma Holdings, Inc.

Chief Scientific Officer
Updated Dec 15, 2021
Form 4
275.00K
Dec 15, 2021
275.00K
Grant
Dec 14
Form 4
31.71%
462.15K
Sep 14, 2021
1.92M
Acquisition
Sep 03
Form 4
1.96%
27.99K
Jun 24, 2021
1.46M
Options
Jun 19
Form 4
200.00K
Jan 04, 2021
200.00K
Grant
Jan 01
Form 4
0.21%
3.00K
Jun 24, 2020
1.43M
Acquisition
Jun 23
Form 4
50.00K
Jun 19, 2020
50.00K
Grant
Jun 17
Form 4
7.16%
102.00K
Jan 03, 2020
1.53M
Acquisition
Jun 21 - Jan 01
Form 4
150.00K
Feb 13, 2019
150.00K
Grant
Feb 11
Form 4
10.00
$1,000.00
$10.00K
Jun 22, 2018
10.00
Purchase
Jun 21
Form 4
150.00K
May 02, 2018
150.00K
Grant
Apr 30
Form 4
0.35%
5.00K
$1.41
$7.05K
Sep 15, 2017
1.42M
Purchase
Sep 11
Form 3
Mar 01, 2017
1.42M
Showing 12 results